Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
J Pediatr Health Care
This is clinically significant because metabolic dysfunction-associated steatotic liver disease (MASLD) previously known as non-alcoholic fatty liver disease (NAFLD) is estimated to affect approximately 2530% of adults in the UK (British Liver Trust), and can progress to cirrhosis and liver failure if untreated
On June 6, Pfizer published detailed Phase 2b data for berobenatide (PF3944), positioning it as a potential first-in-class once-monthly GLP-1 receptor agonist peptideand laid out a wide Phase 3 plan for 2026
This is not optional caution
US$ 20.17
US$ 20.27
US$ 20.72
US$ 23.43
US$ 26.02
US$ 25.56
